Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (711-720 of 1,211) with videos related to

Pageof 122
Sort By:
JACC. Advances|November 13, 2023
Association of Atrial Fibrillation With Stroke and Dementia Accounting for Left Atrial Function and SizeMichael J Zhang, Yuekai Ji, Wendy Wang, et al.
European Journal of Heart Failure|March 2, 2026
Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
European Heart Journal|August 29, 2025
Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failureKieran F Docherty, Benjamin Heywood, Antoni Bayes-Genis, et al.
European Heart Journal|August 31, 2025
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trialMisato Chimura, Kieran F Docherty, Pardeep S Jhund, et al.
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
Circulation|September 9, 2022
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic SubstudyAmil M Shah, Brian Claggett, Narayana Prasad, et al.
Hypertension (Dallas, Tex. : 1979)|October 29, 2014
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities studyYashashwi Pokharel, Wensheng Sun, James A de Lemos, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
Circulation|November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fractionSøren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
Pageof 122

Showing results (711-720 of 1,211) with videos related to

Sort By:
Pageof 122
JACC. Advances|November 13, 2023
Association of Atrial Fibrillation With Stroke and Dementia Accounting for Left Atrial Function and SizeMichael J Zhang, Yuekai Ji, Wendy Wang, et al.
European Journal of Heart Failure|March 2, 2026
Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
European Heart Journal|August 29, 2025
Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failureKieran F Docherty, Benjamin Heywood, Antoni Bayes-Genis, et al.
European Heart Journal|August 31, 2025
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trialMisato Chimura, Kieran F Docherty, Pardeep S Jhund, et al.
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
Circulation|September 9, 2022
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic SubstudyAmil M Shah, Brian Claggett, Narayana Prasad, et al.
Hypertension (Dallas, Tex. : 1979)|October 29, 2014
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities studyYashashwi Pokharel, Wensheng Sun, James A de Lemos, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
Circulation|November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fractionSøren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
Pageof 122